University of Minnesota's Internationally Recognized Stem Cell Experts Available for Interviews on What Lifting the Federal Funding Restrictions Will Mean to Stem Cell Research and to Patients Who Stand to Benefit
Posted on: Thursday, 29 January 2009, 10:41 CST
Slack can speak about how eliminating the restrictions will impact stem cell research. "A lift on the stem cell restrictions will be great for science." Slack says the change will prompt more researchers to get into the study of embryonic stem cells, more researchers will be able to study the stem cells and that means that possible treatments will get to patients more quickly. Embryonic stem cells can be studied with federal funding now, if they were developed before the
"When Bush made that policy, it was estimated that 60 to 70 lines were eligible," Kauman says. But, the number of lines actually available and usable hovers closer to 12-15; meanwhile, the number of hESC lines available worldwide has grown to about 1,000, he says. Until now, Kaufman says, "people using approved human hESC lines could use only about 1 percent of those available." Kaufman is studying the development of normal blood cells and creating populations of "natural killer" white blood cells that specialize in attacking cancer cells or HIV. He has used hESCs from federally approved lines to make natural killer cells, but looks forward to having a wider choice of cells to work with.
Firpo works on stem cell biology, and potential transplantation therapies for diabetes using human embryonic stem cells as well as other types of stem cells. If former President Bush's federal funding restrictions on embryonic stem cell research are lifted, it will have a major impact, Firpo says. The
SOURCE
Source: PR Newswire
Related Articles
- Endocrine Society Calls For Expanded Scope And Funding For Stem Cell Research
- International Stem Cell Corporation Signs Agreement With BioTime, Inc., And Embryome Sciences, Inc., To Provide Unique Human Stem Cell Lines for Research Use
- International Stem Cell Corporation Signs Letter of Intent With BioTime, Inc., And Embryome Sciences to Provide Unique Human Stem Cell Lines for Research Use
- Stem Cell Research Bill Resurfaces in Congress
- Affymetrix Microarrays Uncover Genetic Mutations in Embryonic Stem Cells Approved for Federally-Funded Research; Scientists Report That Majority of Cells Develop Mutations Over Time
- U.S. Embryonic Stem Cell Lines Contaminated
- Bush Administration Still Won't Budge on Stem Cell Research
- Scientists Isolate 12 New Stem Cell Lines
- Scientists Give Free Access to Stem Cell Lines
User Comments (0)

RSS Feeds